Skip to main content
Premium Trial:

Request an Annual Quote

ZyGem, Saudi Diagnostics Reach OEM Deal

NEW YORK (GenomeWeb News) – ZyGem today announced an original equipment manufacturing deal with Saudi Diagnostics for ZyGem's DNA and RNA extraction kits.

Financial and other terms of the deal were not disclosed.

Saudi Diagnostics was established by the King Faisal Specialist Hospital & Research Centre (KFSHRC) as part of the Saudi government's efforts to develop a biotechnology sector in the Kingdom. The company serves as the hospital's commercial arm for developing and spinning out new biotech firms.

Saudi Diagnostics specializes in developing molecular genetic tests that are "unique in their relevance to Arab populations," ZyGem said in a statement, adding that Saudi Diagnostics is the first company to offer molecular diagnostics tests in the Arab Middle East that meet the quality standards of the College of American Pathologists.

Khalid Khabar, director of the program in biomolecular research at KFSHRC, said that the deal with ZyGem "will help [Saudi Diagnostics] to rapidly develop and expand its product base and provide services at the cutting edge of science and technology."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.